Related Experiment Video
Updated: Jun 12, 2025
10:16
Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
8.5K
Nocturnal sleep phenotypes in idiopathic hypersomnia - A data-driven cluster analysis.
Paul Christian Baier1, Hildur Sahlström2, Agneta Markström3
1University Hospital Schleswig-Holstein, Department of Psychiatry and Psychotherapy, Kiel, Germany.
Sleep Medicine
|September 19, 2024
Summary
Idiopathic hypersomnia (IH) patients can be divided into two subgroups with distinct sleep patterns. This finding may lead to more personalized treatments for excessive daytime sleepiness.
Area of Science:
- Sleep Medicine
- Neurology
- Clinical Research
Background:
- Idiopathic hypersomnia (IH) diagnosis is challenging due to varied causes of daytime sleepiness and unclear pathophysiology.
- Current diagnostic tools like the Multiple Sleep Latency Test (MSLT) may not fully capture IH's complexity.
- Understanding IH heterogeneity is crucial for developing individualized treatment strategies.
Purpose of the Study:
- To identify distinct subgroups within idiopathic hypersomnia (IH) patient population using cluster analysis of polysomnography (PSG) data.
- To investigate the temporal evolution of symptoms within these identified subgroups.
- To enhance the understanding and personalization of IH treatment approaches.
Main Methods:
- A cohort of 69 individuals diagnosed with IH according to ICSD-3 criteria were analyzed.
- Two-step cluster analysis was performed on polysomnography (PSG) data, focusing on sleep stage allocation and sleep efficiency.
- Symptomatology was tracked over time (21-179 months) to assess changes within identified subgroups.
Main Results:
- Two distinct IH subgroups emerged: Cluster 1 (42%) with increased deep sleep and higher sleep maintenance efficiency, and Cluster 2 (58%).
- Cluster 1 showed shorter wake after sleep onset but no significant differences in MSLT, BMI, age, or self-reported measures.
- Long-term follow-up revealed overall improvement in excessive daytime sleepiness, with no significant differences between the clusters.
Conclusions:
- Exploratory cluster analysis identified two IH subgroups with differing nocturnal sleep characteristics, supporting the concept of IH phenotypes.
- These findings suggest that idiopathic hypersomnia may comprise multiple phenotypes, potentially necessitating tailored therapeutic interventions.
- Further research is required to validate these subgroups and inform personalized treatment strategies for IH.
More Related Videos
Related Concept Videos
01:07Narcolepsy
94
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
94
01:24Sleep-Wake Cycles
1.2K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.2K
01:19Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
01:27Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79
01:15REM Sleep Behavior Disorder
161
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
161
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
157
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
157